Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors

Ipilimumab is a monoclonal antibody that enhances the efficacy of the immune system by targeting a cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), which is a protein receptor that downregulates the immune system. Nivolumab is also a humanized monoclonal antibody that targets another protein re...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Alexey, Kasso, Nawara, Torloni, Antonio Sergio, Stanek, Michael, Dragovich, Tomislav, Gimbel, Mark, Mahmoud, Fade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317083/
https://www.ncbi.nlm.nih.gov/pubmed/30671268
http://dx.doi.org/10.1155/2018/2464619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317083/
https://www.ncbi.nlm.nih.gov/pubmed/30671268
http://dx.doi.org/10.1155/2018/2464619

Ejemplares similares